BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9171635)

  • 1. Risperidone and neuroleptic malignant syndrome. Recognizing a potentially fatal condition.
    Shuster J
    Nursing; 1997 Mar; 27(3):68. PubMed ID: 9171635
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed risperidone-induced neuroleptic malignant syndrome.
    Kern JL; Cernek PK
    Ann Pharmacother; 1996 Mar; 30(3):300. PubMed ID: 8833573
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
    Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
    Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M; Adityanjee ; Jampala C
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in the burns patient?
    Cawrse N; Wilson S; Williams M; Burge T
    Burns; 2006 Aug; 32(5):647-9. PubMed ID: 16777336
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.
    Isbister GK; Dawson AH; Whyte IM
    Ann Pharmacother; 2002; 36(7-8):1293; author reply 1294. PubMed ID: 12086569
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone and neuroleptic malignant syndrome.
    Tarsy D
    JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant neuroleptic syndrome and hyponatremia associated with risperidone poisoning].
    Epelde Gonzalo F
    An Med Interna; 2002 Jan; 19(1):50. PubMed ID: 11989083
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA; Millaud F; Nguyen KA
    Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA; Kuiper J; Verwey B
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract]   [Full Text] [Related]  

  • 19. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.